COMPANY INFORMATION
Registered name: Summit Therapeutics plc
Country of incorporation: England & Wales
Main country of operation: United Kingdom
Registered address: 136a Eastern Avenue
Milton Park
Abingdon
Oxfordshire
OX14 4SB
United Kingdom
Company Secretary: Melissa Strange, FCCA
Registered number: 05197494
VAT number: 876331407

 

TAKEOVER CODE

Summit Therapeutics plc is subject to the UK City Code on Takeovers and Mergers.

 

CONSTITUTIONAL DOCUMENTS

The Company’s current articles of association can be viewed here:

Articles of Association (pdf 233KB)

 

ADMISSION DOCUMENT

The Company’s Admission Document to AIM, a market of the London Stock Exchange is available:

Admission Document (pdf)

Please note this document was issued more than twelve years ago and is accordingly substantially out of date. For more accurate and up-to-date information, please refer to other sections of this website, the latest Annual Report, our filings with the US Securities & Exchange Commission, recent regulatory announcements and other such information sources on the web.